CNSDose

Health Technology

A personalised medicine company that quickly and accurately predicts medication for patients based on genetic testing.

CNSdose is a personalised medicine company that uses advanced genetic testing to fast-track correct medication diagnosis across a patient's lifespan.

Harris Eyre

Chief Medical Officer

Harris A. Eyre MBBS, PhD is a global personalised mental health executive. His mission is to reduce trial-and-error and wait-and-see approaches to mental health care by leveraging technology and innovation, such as genomics, machine learning and smart-phone technology. Harris is Chief Medical Officer of CNSdose, a company specialising in advanced genetic guidance of mental health medications. Harris is a member of the Stakeholder Advisory Board of OPTIMUM PCORI Study, the world's largest late-life antidepressant trial, and is an Entrepreneur-In-Residence at Texas Medical Centre’s Innovation Institute. He has published 80+ articles in outlets including World Psychiatry and Am J Psychiatry. His work has been covered in the NYT and Newsweek.

Want to get in touch?

Contact Us
Melbourne Accelerator Program
Level 1, 333 Exhibition Street
Melbourne, Victoria 3000

Get Directions
An initiative of the University of Melbourne.
Copyright 2019. All rights reserved.